Perspective Therapeutics, Inc. (CATX)
USD 2.0
(4.17%)
USD 2.0
(4.17%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | 7.1 Million USD | -34.19% |
| 2021 | 10.79 Million USD | 7.38% |
| 2020 | 10.05 Million USD | 3.85% |
| 2019 | 9.68 Million USD | 32.35% |
| 2018 | 7.31 Million USD | 23.48% |
| 2017 | 5.92 Million USD | 24.41% |
| 2016 | 4.76 Million USD | -0.17% |
| 2015 | 4.76 Million USD | 3.53% |
| 2014 | 4.6 Million USD | 9.18% |
| 2013 | 4.21 Million USD | -6.76% |
| 2012 | 4.52 Million USD | -10.76% |
| 2011 | 5.07 Million USD | -3.2% |
| 2010 | 5.23 Million USD | -0.89% |
| 2009 | 5.28 Million USD | -2.43% |
| 2008 | 5.41 Million USD | -24.32% |
| 2007 | 7.15 Million USD | 24.76% |
| 2006 | 5.73 Million USD | 187.72% |
| 2005 | 1.99 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | -100.0% |
| 1996 | 7.84 Million USD | -4.96% |
| 1995 | 8.25 Million USD | 5.64% |
| 1994 | 7.81 Million USD | 15.16% |
| 1993 | 6.78 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q1 | 1.9 Million USD | 27.27% |
| 2022 Q3 | 1.83 Million USD | -0.27% |
| 2022 Q1 | 1.71 Million USD | -31.46% |
| 2022 Q2 | 1.83 Million USD | 6.87% |
| 2022 FY | 7.1 Million USD | -34.19% |
| 2022 Q4 | 1.5 Million USD | -18.03% |
| 2021 Q3 | 2.91 Million USD | 3.34% |
| 2021 Q1 | 2.56 Million USD | -5.39% |
| 2021 FY | 10.79 Million USD | 7.38% |
| 2021 Q4 | 2.5 Million USD | -13.92% |
| 2021 Q2 | 2.81 Million USD | 9.83% |
| 2020 Q3 | 2.6 Million USD | 10.22% |
| 2020 Q2 | 2.35 Million USD | -1.05% |
| 2020 Q1 | 2.38 Million USD | 4.61% |
| 2020 FY | 10.05 Million USD | 3.85% |
| 2020 Q4 | 2.71 Million USD | 4.23% |
| 2019 Q3 | 2.88 Million USD | 30.55% |
| 2019 FY | 9.68 Million USD | 32.35% |
| 2019 Q1 | 2.31 Million USD | 20.32% |
| 2019 Q2 | 2.2 Million USD | -4.71% |
| 2019 Q4 | 2.27 Million USD | -20.87% |
| 2018 Q1 | 1.56 Million USD | -2.56% |
| 2018 Q2 | 1.9 Million USD | 21.9% |
| 2018 Q3 | 1.92 Million USD | 1.05% |
| 2018 Q4 | 1.92 Million USD | 0.0% |
| 2018 FY | 7.31 Million USD | 23.48% |
| 2017 Q3 | 1.57 Million USD | 2.41% |
| 2017 FY | 5.92 Million USD | 24.41% |
| 2017 Q2 | 1.53 Million USD | 26.84% |
| 2017 Q1 | 1.21 Million USD | -11.61% |
| 2017 Q4 | 1.6 Million USD | 1.91% |
| 2016 Q1 | 1.08 Million USD | -3.5% |
| 2016 FY | 4.76 Million USD | -0.17% |
| 2016 Q4 | 1.37 Million USD | 6.86% |
| 2016 Q3 | 1.28 Million USD | 24.71% |
| 2016 Q2 | 1.02 Million USD | -4.9% |
| 2015 FY | 4.76 Million USD | 3.53% |
| 2015 Q4 | 1.12 Million USD | -6.55% |
| 2015 Q3 | 1.19 Million USD | 0.82% |
| 2015 Q2 | 1.18 Million USD | -5.73% |
| 2015 Q1 | 1.26 Million USD | -5.92% |
| 2014 Q2 | 1.06 Million USD | 2.25% |
| 2014 Q1 | 1.04 Million USD | 9.75% |
| 2014 Q4 | 1.34 Million USD | 15.77% |
| 2014 FY | 4.6 Million USD | 9.18% |
| 2014 Q3 | 1.15 Million USD | 8.68% |
| 2013 Q2 | 1.08 Million USD | 3.38% |
| 2013 FY | 4.21 Million USD | -6.76% |
| 2013 Q1 | 1.04 Million USD | -15.47% |
| 2013 Q4 | 949.51 Thousand USD | -16.29% |
| 2013 Q3 | 1.13 Million USD | 4.51% |
| 2012 Q1 | 1.05 Million USD | -19.47% |
| 2012 FY | 4.52 Million USD | -10.76% |
| 2012 Q3 | 1.25 Million USD | 28.3% |
| 2012 Q2 | 975.45 Thousand USD | -7.65% |
| 2012 Q4 | 1.24 Million USD | -0.75% |
| 2011 FY | 5.07 Million USD | -3.2% |
| 2011 Q3 | 1.31 Million USD | 7.22% |
| 2011 Q4 | 1.31 Million USD | -0.43% |
| 2011 Q1 | 1.21 Million USD | -3.41% |
| 2011 Q2 | 1.22 Million USD | 1.26% |
| 2010 Q1 | 1.32 Million USD | -0.62% |
| 2010 FY | 5.23 Million USD | -0.89% |
| 2010 Q2 | 1.24 Million USD | -6.19% |
| 2010 Q3 | 1.41 Million USD | 13.32% |
| 2010 Q4 | 1.25 Million USD | -10.95% |
| 2009 FY | 5.28 Million USD | -2.43% |
| 2009 Q1 | 1.37 Million USD | 14.42% |
| 2009 Q3 | 1.2 Million USD | -12.07% |
| 2009 Q4 | 1.33 Million USD | 10.99% |
| 2009 Q2 | 1.36 Million USD | -0.78% |
| 2008 Q2 | 1.32 Million USD | -12.69% |
| 2008 FY | 5.41 Million USD | -24.32% |
| 2008 Q1 | 1.51 Million USD | -13.71% |
| 2008 Q4 | 1.2 Million USD | -11.79% |
| 2008 Q3 | 1.36 Million USD | 2.98% |
| 2007 Q2 | 1.75 Million USD | -5.25% |
| 2007 Q1 | 1.85 Million USD | 12.28% |
| 2007 Q4 | 1.76 Million USD | -1.27% |
| 2007 FY | 7.15 Million USD | 24.76% |
| 2007 Q3 | 1.78 Million USD | 1.44% |
| 2006 Q4 | 1.65 Million USD | 0.43% |
| 2006 Q2 | 1.41 Million USD | 37.91% |
| 2006 Q1 | 1.02 Million USD | 25.37% |
| 2006 FY | 5.73 Million USD | 187.72% |
| 2006 Q3 | 1.64 Million USD | 16.37% |
| 2005 Q3 | 479.22 Thousand USD | -1.44% |
| 2005 Q2 | 486.24 Thousand USD | 130.54% |
| 2005 Q4 | 817.91 Thousand USD | 70.68% |
| 2005 FY | 1.99 Million USD | 0.0% |
| 2005 Q1 | 210.91 Thousand USD | 0.0% |
| 2004 Q2 | 130 Thousand USD | 0.0% |
| 2004 Q3 | 210.91 Thousand USD | 62.24% |
| 2004 Q1 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 FY | - USD | -100.0% |
| 1996 FY | 7.84 Million USD | -4.96% |
| 1995 FY | 8.25 Million USD | 5.64% |
| 1994 FY | 7.81 Million USD | 15.16% |
| 1993 FY | 6.78 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Electromed, Inc. | 54.71 Million USD | 87.017% |
| Senseonics Holdings, Inc. | 22.39 Million USD | 68.272% |
| Catheter Precision, Inc. | 442 Thousand USD | -1507.24% |
| Xtant Medical Holdings, Inc. | 91.3 Million USD | 92.219% |